25 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 25 of 25 clinical reviews.
A clinical deep-dive into tirzepatide (Zepbound) use after bariatric surgery, covering pharmacokinetics, dosing, safety, and the evidence base for post-bariatric GLP-1/GIP therapy.
A clinician-level review of how Zepbound (tirzepatide) changes appetite, food cravings, and eating behavior, with primary-literature citations from SURMOUNT-1 and related mechanistic studies.
A clinician-reviewed guide to using Zepbound (tirzepatide) in patients with autoimmune disease, covering immunologic mechanisms, disease-specific risks, drug interactions, and monitoring protocols backed by primary-literature citations.
A clinical deep-dive into how tirzepatide (Zepbound) affects bone mineral density, fracture risk, and bone turnover markers, with primary-literature citations and practical monitoring guidance.
A physician-reviewed analysis of tirzepatide (Zepbound) cancer risk signals, including rodent thyroid findings, post-marketing data, and what current guidelines recommend for screening before and during treatment.
A deep clinical review of tirzepatide's long-term cardiovascular effects, covering SURMOUNT, SURPASS-CVOT, and SURMOUNT-OSA trial data, blood pressure changes, lipid effects, and what to expect over 1-3 years of treatment.
A physician-reviewed deep dive into tirzepatide's effects on cognition, brain inflammation, and neurological markers, with primary-literature citations and clinical guidance.
A physician-reviewed comparison of compounded tirzepatide versus branded Zepbound, covering efficacy, safety, regulatory status, cost, and how to choose between them.
A GRADE-level review of tirzepatide (Zepbound) for chronic weight management, covering SURMOUNT-1 through SURMOUNT-4, cardiovascular outcomes, and real-world data with primary-literature citations.
A clinical deep-dive into tirzepatide-related hair loss, skin changes, and what patients and clinicians can do about them, grounded in SURMOUNT-1 data and primary literature.
A physician-reviewed deep dive into how Zepbound (tirzepatide) affects liver function, including ALT/AST changes, MASLD/NASH outcomes, and what monitoring looks like in practice.
A clinician-reviewed breakdown of how tirzepatide (Zepbound) affects mood, depression, anxiety, and psychological wellbeing, with primary-literature citations and practical guidance.
A detailed review of how tirzepatide (Zepbound) affects resting metabolic rate, thermogenesis, fat oxidation, and energy balance, with primary-literature citations at every key claim.
A clinician-level review of tirzepatide microdosing protocols for weight management, including SURMOUNT-1 data, off-label dose reduction strategies, tolerability evidence, and practical prescribing guidance.
Evidence-based strategies to preserve lean mass during tirzepatide (Zepbound) therapy, including protein targets, resistance training protocols, and monitoring benchmarks used by HealthRX.com clinicians.
Why Zepbound (tirzepatide) weight loss stalls and exactly what to do about it: dose optimization, adherence audits, metabolic workup, and add-on strategies backed by SURMOUNT trial data and clinical guidelines.
Learn exactly how long to hold Zepbound (tirzepatide) before surgery, why anesthesiologists require it, what guidelines say, and how to manage your weight regimen around an operation.
What happens to your weight when you stop Zepbound (tirzepatide)? Learn what SURMOUNT-4 found, how much weight returns, why it happens, and what your clinical options are.
A physician-reviewed analysis of tirzepatide's effects on kidney function, including SURMOUNT-1 data, GFR changes, albuminuria findings, and clinical guidance for patients with CKD.
Everything patients and clinicians need to know about safely restarting tirzepatide (Zepbound) after an acute illness, including dose step-down protocols, hydration rules, and when to call your provider.
How seasons affect Zepbound (tirzepatide) dosing, tolerability, hydration, appetite, and weight loss outcomes. Evidence-based guidance for clinicians and patients managing chronic obesity year-round.
Does Zepbound (tirzepatide) improve or harm sexual function? We review SURMOUNT-1 and related evidence on erectile function, libido, hormone changes, and what patients can expect.
A clinician-level review of how Zepbound (tirzepatide) changes sleep architecture, reduces OSA severity, and alters slow-wave and REM sleep. Includes SURMOUNT-1, SURMOUNT-OSA, and mechanistic data.
Everything you need to know about traveling with Zepbound (tirzepatide): injection timing, storage across time zones, nausea management in transit, and what to do if you miss a dose mid-trip.
A clinician-reviewed, week-by-week guide to your first 4 weeks on Zepbound (tirzepatide): expected weight loss, side effects, dose schedule, and when to call your prescriber.